Does TIRBANIBULIN Cause Therapeutic product effect incomplete? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic product effect incomplete have been filed in association with TIRBANIBULIN (Klisyri). This represents 2.5% of all adverse event reports for TIRBANIBULIN.
5
Reports of Therapeutic product effect incomplete with TIRBANIBULIN
2.5%
of all TIRBANIBULIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From TIRBANIBULIN?
Of the 5 reports.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRBANIBULIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TIRBANIBULIN Cause?
Drug ineffective (44)
Application site erythema (31)
Drug intolerance (20)
Erythema (18)
Adverse drug reaction (17)
Application site exfoliation (17)
Application site vesicles (14)
Application site pain (12)
Off label use (11)
Application site dryness (10)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which TIRBANIBULIN Alternatives Have Lower Therapeutic product effect incomplete Risk?
TIRBANIBULIN vs TIROFIBAN
TIRBANIBULIN vs TIRZEPATIDE
TIRBANIBULIN vs TISAGENLECLEUCEL
TIRBANIBULIN vs TISLELIZUMAB
TIRBANIBULIN vs TISOTUMAB VEDOTIN